ABERCROMBIE GEORGE B has filed 4 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 6820 shares of BIOCRYST PHARMACEUTICALS INC ($BCRX) on June 12, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 12, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | ABERCROMBIE GEORGE B | Director | A | Common Stock | 6820 | $0.00 | 36,431.0000 | 192,198,000 | 23.03% | 0.00% |
| June 12, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | ABERCROMBIE GEORGE B | Director | A | Automatic Stock Option Grant | 49933 | $0.00 | 49,933.0000 | 192,198,000 | 9999.99% | 0.03% |
| June 13, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | ABERCROMBIE GEORGE B | Director | A | Common Stock | 16745 | $0.00 | 29,611.0000 | 185,908,000 | 130.15% | 0.01% |
| June 13, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | ABERCROMBIE GEORGE B | Director | A | Automatic Stock Option Grant | 39072 | $0.00 | 39,072.0000 | 185,908,000 | 9999.99% | 0.02% |